For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

16 March 2010
The inappropriate use of diagnostic imaging has been recognised as an issue by government, and in August the National Prescribing Service will begin the first phase of its program to improve referrals for diagnostics.
This program was announced in the last federal budget, with funding of $9.4 million over four years to improve the use of diagnostic tools including CT scans, pathology and other diagnostic technologies.
The NPS program will focus on improving requests by doctors for pathology and diagnostic tests, and draws on the same successful model it has used over the last decade to improve medicines use.
“Our model for improving medicines use in Australia has been extremely successful. It focuses on both education of health professionals and of consumers, and we are proud to say that we have achieved significant changes in prescribing behaviour. For some medicines this has meant a decrease in prescribing and for others it has meant an increase,” NPS CEO, Dr Lynn Weekes said.
“Our ultimate concern is that medicines and medical technologies are used in the best way possible for the patient’s health.”
The first phase of the NPS program will address technologies used to diagnose lower back pain, as back complaint is the second most common reason why people presented to their doctor asking for analgesics. Back pain generates 5% of imaging orders.
A review of GP activity using the BEACH dataset shows the proportion of encounters generating imaging orders increased from 6.7% in 1999-2000 to 8.5% in 2008-09 (approximately 2.7 million more encounters for which imaging was ordered). Diagnostic radiology accounts for almost half (48.4%) of all imaging ordered in 2008-09.
“One of the difficulties doctors face is that people with lower back pain often expect to be prescribed an x-ray or CT scan in the hope that it will identify the root cause of their pain. In reality, imaging rarely is helpful in guiding the best treatment choices for back pain,” Dr Weekes said.
A diagnostics expert advisory panel has been established and is chaired by Tim Usherwood, Professor of General Practice and Head of Department, Sydney Medical School, Westmead Hospital.
ENDS
The National Prescribing Service Limited (NPS) is an independent, not-for-profit organisation for quality use of medicines funded by the Australian Government Department of Health and Ageing.
Media enquiries
Contact us
Date published: 2010-03-16 19:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.